Family estimates of risk for neurocognitive late effects following pediatric cancer: From diagnosis through the first three years of survivorship

scientific article published on 25 January 2017

Family estimates of risk for neurocognitive late effects following pediatric cancer: From diagnosis through the first three years of survivorship is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/PBC.26462
P698PubMed publication ID28121066

P50authorCynthia A GerhardtQ88490198
Kathryn VannattaQ106415364
P2093author name stringBruce E Compas
Joseph R Rausch
Vicky Lehmann
Randal S Olshefski
Adrien M Winning
Madelaine C Keim
Emily L Shultz
P2860cites workMissing data: our view of the state of the artQ28207899
Inference and missing dataQ29307215
Parental preparedness for late effects and long-term quality of life in survivors of childhood cancerQ30152015
Working memory abilities among children treated for medulloblastoma: parent report and child performanceQ33636808
Transition of care for young adult survivors of childhood and adolescent cancer: rationale and approachesQ34107335
Children and adolescents coping with cancer: self- and parent reports of coping and anxiety/depressionQ34562589
Long-term effects of radiation exposure among adult survivors of childhood cancer: results from the childhood cancer survivor studyQ34822530
Psychosocial and Neurocognitive Outcomes in Adult Survivors of Adolescent and Early Young Adult Cancer: A Report From the Childhood Cancer Survivor StudyQ35916644
Mothers and fathers coping with their children's cancer: Individual and interpersonal processesQ36351303
A meta-analysis of the neurocognitive sequelae of treatment for childhood acute lymphocytic leukemiaQ36455459
Family impact of neurodevelopmental late effects in survivors of pediatric cancer: review of research, clinical evidence, and future directionsQ36642497
Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: a report from the Children's Oncology GroupQ36902667
Potential chemotherapy side effects: what do oncologists tell parents?Q37098727
Processing speed, attention, and working memory after treatment for medulloblastoma: an international, prospective, and longitudinal studyQ37195237
A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia.Q37334592
Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude lifetime cohort studyQ37348625
Dexamethasone exposure and memory function in adult survivors of childhood acute lymphoblastic leukemia: A report from the SJLIFE cohortQ37592251
Monitoring and Assessment of Neuropsychological Outcomes as a Standard of Care in Pediatric OncologyQ38678301
Parent perceptions of the quality of information received about a child's cancerQ39400848
Health literacy variables related to parents' understanding of their child's cancer prognosisQ39638417
Developmental cascades: linking academic achievement and externalizing and internalizing symptoms over 20 yearsQ39730630
Information needs in parents of long-term childhood cancer survivorsQ41461982
Neurotoxicity associated with systemic high-dose cytosine arabinosideQ42216018
Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancerQ42282931
The interplay of social competence and psychopathology over 20 years: testing transactional and cascade modelsQ44623638
A comparison of patient and proxy symptom assessments in advanced cancer patientsQ48732694
Childhood cancer survivors' knowledge about their past diagnosis and treatment: Childhood Cancer Survivor Study.Q50114641
Neuropsychologic effects of chemotherapy on children with cancer: a longitudinal study.Q50616860
Understanding of prognosis among parents of children with cancer: parental optimism and the parent-physician interaction.Q50904864
Predicting Intellectual Outcome Among Children Treated With 35-40 Gy Craniospinal Irradiation for MedulloblastomaQ55472489
P433issue9
P577publication date2017-01-25
P1433published inPediatric Blood & CancerQ15754342
P1476titleFamily estimates of risk for neurocognitive late effects following pediatric cancer: From diagnosis through the first three years of survivorship
P478volume64

Reverse relations

Q42701077Commentary: Dennis D. Drotar Distinguished Research Award: Academic and Personal Reflections on Childhood Cancer Research Across the Illness Spectrumcites workP2860

Search more.